| Meropenem OrPha 500 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung - |
| 70085001 | | OrPha Swiss GmbH | | Meropenem OrPha 500 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung | | 15.12.2025 | | | | | 15.12.2025 | | Meropenem (J01DH02) | | | | WHO-DDD | | 14.12.2030 | | | | | | 08.01.25. | | | | | | | | No | | | | | | | | | | | | k.A. | | | | FB | | | | 7680700850018 | | Synthetika | | | | |
|
| Composition |
| Praeparatio sicca: meropenemum 500 mg ut meropenemum trihydricum, natrii carbonas, pro vitro corresp. natrium 45.05 mg. |
| Packungsbestandteile |
| Dry substance | | | | | | Active Agent | Dose | additional_information |
|---|
| Meropenem | 500 mg | Praeparatio sicca |
| | | | Inactive agents |
|---|
| Sodium Carbonate |
|
|
| Source |
| |
|
|